OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALBC.PK56

Alternative Ballistics Corp

Aerospace & DefenseVerified

Alternative Ballistics Corp has a fully diluted share count of 31,776,036, with no difference between basic and diluted shares, indicating no immediate dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and return metrics are not available in the valuation snapshot, making it difficult to compare with industry_config preferred metrics or cohort medians. Without revenue, EBITDA, or net income figures, a direct assessment of profitability is not possible. The company's revenue concentration and geographic exposure are not disclosed in the input data, so it is unclear whether the business is diversified across segments or regions. This lack of transparency limits the ability to assess exposure to regional or sector-specific risks. Growth trajectory is also indeterminate, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. Without forward-looking guidance or historical performance, it is not possible to assess the company's growth potential. Risk factors include the inability to assess liquidity risk, which could affect the company's ability to meet short-term obligations. The dilution risk is currently low, but the absence of balance-sheet data and going-concern language raises concerns about the company's financial health. Recent events, including filings and transcripts, are not provided in the input data, so no specific developments can be cited. The lack of recent disclosures or updates makes it difficult to evaluate the company's current strategic direction or operational performance.

30-day price · ALBC.PK+0.50 (+23.8%)
Low$1.00High$2.60Close$2.60As of16 May, 00:00 UTC
Profile
CompanyAlternative Ballistics Corp
TickerALBC.PK
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Alternative Ballistics Corp develops and sells less-lethal force tools for law enforcement and home defense, including The Alternative and The Home Defense, which utilize proprietary bullet capture technology to reduce risk in critical incidents.

Classification. The company is classified under the Aerospace & Defense industry within the Industrial Goods business sector, with a confidence level of 0.92 based on verified market data.

Alternative Ballistics Corp has a fully diluted share count of 31,776,036, with no difference between basic and diluted shares, indicating no immediate dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and return metrics are not available in the valuation snapshot, making it difficult to compare with industry_config preferred metrics or cohort medians. Without revenue, EBITDA, or net income figures, a direct assessment of profitability is not possible. The company's revenue concentration and geographic exposure are not disclosed in the input data, so it is unclear whether the business is diversified across segments or regions. This lack of transparency limits the ability to assess exposure to regional or sector-specific risks. Growth trajectory is also indeterminate, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. Without forward-looking guidance or historical performance, it is not possible to assess the company's growth potential. Risk factors include the inability to assess liquidity risk, which could affect the company's ability to meet short-term obligations. The dilution risk is currently low, but the absence of balance-sheet data and going-concern language raises concerns about the company's financial health. Recent events, including filings and transcripts, are not provided in the input data, so no specific developments can be cited. The lack of recent disclosures or updates makes it difficult to evaluate the company's current strategic direction or operational performance.
Key takeaways
  • The company has no immediate dilution risk as basic and diluted shares are equal.
  • Liquidity risk cannot be assessed due to missing balance-sheet data.
  • Profitability and return metrics are not available for comparison with industry benchmarks.
  • Growth trajectory and revenue history are not disclosed, limiting forward-looking analysis.
  • Revenue concentration and geographic exposure are not provided, reducing visibility into risk diversification.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Aerospace & Defense · cohort 6 companies
MetricALBC.PKActivity
Op margin4.8% medp25 0.2% · p75 11.7%
Net margin2.5% medp25 -1.2% · p75 9.3%
Gross margin16.0% medp25 5.1% · p75 29.5%
R&D / revenue2.7% medp25 0.4% · p75 4.0%
CapEx / revenue3.3% medp25 2.7% · p75 3.8%
Debt / equity53.2% medp25 37.6% · p75 76.6%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:34 UTC#38bc122a
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:35 UTCJob: e1b538e6